#pharmapolicy โ Public Fediverse posts
Live and recent posts from across the Fediverse tagged #pharmapolicy, aggregated by home.social.
-
๐๐ฎ๐ป ๐ฏ๐ถ๐ผ๐๐ถ๐บ๐ถ๐น๐ฎ๐ฟ๐ ๐บ๐ฎ๐ธ๐ฒ ๐ฎ๐ฑ๐๐ฎ๐ป๐ฐ๐ฒ๐ฑ ๐๐ต๐ฒ๐ฟ๐ฎ๐ฝ๐ถ๐ฒ๐ ๐บ๐ผ๐ฟ๐ฒ ๐ฎ๐ณ๐ณ๐ผ๐ฟ๐ฑ๐ฎ๐ฏ๐น๐ฒ?
Governments like South Korea are introducing pricing caps on ๐ฏ๐ถ๐ผ๐๐ถ๐บ๐ถ๐น๐ฎ๐ฟ๐, ๐ถ๐บ๐ฝ๐ฟ๐ผ๐๐ถ๐ป๐ด ๐ฎ๐ฐ๐ฐ๐ฒ๐๐๐ถ๐ฏ๐ถ๐น๐ถ๐๐ ๐ฎ๐ป๐ฑ ๐ฏ๐ผ๐ผ๐๐๐ถ๐ป๐ด ๐ฎ๐ฑ๐ผ๐ฝ๐๐ถ๐ผ๐ป across APAC.
๐ฅ๐ฒ๐ฎ๐ฑ ๐บ๐ผ๐ฟ๐ฒ: https://www.kenresearch.com/industry-reports/asia-pacific-biopharmaceuticals-market?utm_source=Mastadon&utm_medium=Social&utm_campaign=Aniket -
Millions still lack access to life-saving medicines, not because science failed, but because patents, prices, and politics get in the way. This deep dive unpacks how countries have used (and sometimes avoided) TRIPS flexibilities over the past 25 years to break monopolies,
Read more: https://gh.bmj.com/content/11/1/e021481
#AccessToMedicines #TRIPS #PublicHealth #MedicineQuality #GlobalHealth #HealthEquity #GenericMedicines #PharmaPolicy #IPandHealth #Quamed
-
Millions still lack access to life-saving medicines, not because science failed, but because patents, prices, and politics get in the way. This deep dive unpacks how countries have used (and sometimes avoided) TRIPS flexibilities over the past 25 years to break monopolies,
Read more: https://gh.bmj.com/content/11/1/e021481
#AccessToMedicines #TRIPS #PublicHealth #MedicineQuality #GlobalHealth #HealthEquity #GenericMedicines #PharmaPolicy #IPandHealth #Quamed